UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

1088-P: A PK/PD and Metabolic Head-to-Head Comparison of Clinical Doses of Insulin Glargine U300 and Degludec in Type 1 Diabetes

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

42 IL-6 as prognostic factor in adjuvant or metastatic skin cancer patients treated with immunotherapy – a deep biomarker analysis

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A47-A47

2023

Volltextzugriff (PDF)

579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A658-A659

2023

Volltextzugriff (PDF)

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

Journal of translational medicine, 2023-02, Vol.21 (1), p.140-140, Article 140

2023

Volltextzugriff (PDF)

895-P: Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

ACAMPROSATE DOES NOT ANTAGONISE THE DISCRIMINATIVE STIMULUS PROPERTIES OF AMPHETAMINE AND MORPHINE IN RATS

Pharmacological research, 1999-10, Vol.40 (4), p.333-338

1999

Volltextzugriff (PDF)

Acute polyneuropathy and intracerebral hemorrhage as uncommon presentation in Churg Strauss syndrome

Journal of the neurological sciences, 2021-10, Vol.429, p.118827, Article 118827

2021

Volltextzugriff (PDF)

Can Early Neurosonology Predict Outcome in Acute Stroke? : A Metaanalysis of Prognostic Clinical Effect Sizes Related to the Vascular Status

Stroke (1970), 2008-12, Vol.39 (12), p.3255-3261

2008

Volltextzugriff (PDF)

Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli

Molecular and biochemical parasitology, 1995, Vol.75 (1), p.99-111

1995

Volltextzugriff (PDF)

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

Diabetes (New York, N.Y.), 2008-03, Vol.57 (3), p.746-756

2008

Volltextzugriff (PDF)

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus

Diabetes care, 2011-12, Vol.34 (12), p.2521-2523

2011

Volltextzugriff (PDF)

Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglyceima in nondiabetic and type 1 diabetic people

Diabetes (New York, N.Y.), 2008-07, Vol.57 (7), p.1905

2008

Volltextzugriff (PDF)

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

Diabetes (New York, N.Y.), 2008-07, Vol.57 (7), p.1905-1917

2008

Volltextzugriff (PDF)

Expression cloning and biochemical characterizations of recombinant cyclophilin proteins from Schistosoma mansoni

Protein expression and purification, 1998-04, Vol.12 (3), p.340-346

1998

Volltextzugriff (PDF)

Expression Cloning and Biochemical Characterizations of Recombinant Cyclophilin Proteins fromSchistosoma mansoni

Protein expression and purification, 1998-04, Vol.12 (3), p.340-346

1998

Volltextzugriff (PDF)

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma

Cancer Immunology, Immunotherapy : CII, 2024-06, Vol.73 (8), p.160, Article 160

2024

Volltextzugriff (PDF)

Lower Pharmacokinetic and Pharmacodynamic Within-Day Variability of Individual Clinical Doses of Insulin Glargine 300 U/ml vs. Glargine 100 U/ml in T1DM

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Volltextzugriff (PDF)

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

Diabetes care, 2012-12, Vol.35 (12), p.2647-2649

2012

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL -1 and Insulin Degludec 100 units · mL -1 in Type 1 Diabetes

Diabetes care, 2021-01, Vol.44 (1), p.125-132

2021

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes

Diabetes care, 2015-03, Vol.38 (3), p.503-512

2015

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

Diabetes care, 2015-12, Vol.38 (12), p.2204-2210

2015

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

Diabetes care, 2011-06, Vol.34 (6), p.1312-1314

2011

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study

Diabetes care, 2011-06, Vol.34 (6), p.1312-1314

2011

Volltextzugriff (PDF)

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Diabetes care, 2019-01, Vol.42 (1), p.85-92

2019

Volltextzugriff (PDF)

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

Diabetes (New York, N.Y.), 2009-01, Vol.58 (1), p.194-202

2009

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(13)
Insulin
(12)
Diabetes
(10)
Endocrinology & Metabolism
(10)
Male
(10)
Glucose
(9)
Biological And Medical Sciences
(8)
Female
(8)
Medical Sciences
(8)
Endocrinopathies
(7)
Adult
(6)
Diabetes. Impaired Glucose Tolerance
(6)
Endocrine Pancreas. Apud Cells
(6)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(6)
Hypoglycemic Agents - Administration & Dosage
(6)
Animals
(5)
Blood Glucose - Metabolism
(5)
Glucose Clamp Technique
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

1088-P: A PK/PD and Metabolic Head-to-Head Comparison of Clinical Doses of Insulin Glargine U300 and Degludec in Type 1 Diabetes

42 IL-6 as prognostic factor in adjuvant or metastatic skin cancer patients treated with immunotherapy – a deep biomarker analysis

579 Evaluation of cemiplimab treatment duration: clinical outcomes in advanced CSCC

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab

895-P: Improved Glycemic Control with Insulin Glargine 300 U/mL vs. Glargine 100 U/mL in Type 1 Diabetes

ACAMPROSATE DOES NOT ANTAGONISE THE DISCRIMINATIVE STIMULUS PROPERTIES OF AMPHETAMINE AND MORPHINE IN RATS

Acute polyneuropathy and intracerebral hemorrhage as uncommon presentation in Churg Strauss syndrome

Can Early Neurosonology Predict Outcome in Acute Stroke? : A Metaanalysis of Prognostic Clinical Effect Sizes Related to the Vascular Status

Characterization of a Schistosoma mansoni cDNA encoding a B-like cyclophilin and its expression in Escherichia coli

Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus

Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglyceima in nondiabetic and type 1 diabetic people

Effect of Oral Amino Acids on Counterregulatory Responses and Cognitive Function During Insulin-Induced Hypoglycemia in Nondiabetic and Type 1 Diabetic People

Expression cloning and biochemical characterizations of recombinant cyclophilin proteins from Schistosoma mansoni

Expression Cloning and Biochemical Characterizations of Recombinant Cyclophilin Proteins fromSchistosoma mansoni

Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma

Lower Pharmacokinetic and Pharmacodynamic Within-Day Variability of Individual Clinical Doses of Insulin Glargine 300 U/ml vs. Glargine 100 U/ml in T1DM

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

Pharmacokinetic and Pharmacodynamic Head-to-Head Comparison of Clinical, Equivalent Doses of Insulin Glargine 300 units · mL -1 and Insulin Degludec 100 units · mL -1 in Type 1 Diabetes

Pharmacokinetics and pharmacodynamics of insulin glargine given in the evening as compared with in the morning in type 2 diabetes

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects: A randomized cross-over study

Pharmacokinetics, Pharmacodynamics, and Modulation of Hepatic Glucose Production With Insulin Glargine U300 and Glargine U100 at Steady State With Individualized Clinical Doses in Type 1 Diabetes

Portal Vein Glucose Sensors Do Not Play a Major Role in Modulating Physiological Responses to Insulin-Induced Hypoglycemia in Humans

Suchergebnisse filtern